Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 1/20 | 0.46 |
| ▸ | PNP | P00491 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3139870 | 0.86 | MEN1 (0.48) | TK1PNPTSHRMEN1KMT2A | |
| SCHEMBL24709731 | 0.79 | PNP (0.66) | TK1PNPTSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL23453027 | 0.78 | HTT (0.51) | MAPK1RAB9AHTTSMN1; SMN2KMT2A | |
| SCHEMBL3132950 | 0.76 | MEN1 (0.46) | TK1TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL14548981 | 0.74 | MEN1 (0.42) | TK1PNPTSHRMEN1KMT2A | |
| SCHEMBL10077237 | 0.74 | RAB9A (0.40) | PNPTSHRMAPK1RAB9A | |
| SCHEMBL3136226 | 0.73 | TK1 (0.46) | TK1TSHRMEN1KMT2A | |
| SCHEMBL3127339 | 0.72 | MEN1 (0.44) | TK1TSHRMEN1KMT2A | |
| SCHEMBL10047129 | 0.72 | TSHR (0.49) | TK1TSHRRAB9AMEN1KMT2A | |
| SCHEMBL13196024 | 0.71 | RAF1 (0.43) | TK1PNPTSHRRAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163541-A1 | Method for Preparing PNA Oligomer | SEASUNBIO MATERIALS (KR) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163541-A1 | Method for Preparing PNA Oligomer | NCL, NOD1, POLI | TK1 2449/4885PNP 173/4885TSHR 2495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.